BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19181031)

  • 41. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E; Kircik L; Wilson D; Dhawan S
    J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating acne with antibiotic-resistant bacterial colonization.
    Tzellos T; Zampeli V; Makrantonaki E; Zouboulis CC
    Expert Opin Pharmacother; 2011 Jun; 12(8):1233-47. PubMed ID: 21355786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical benzoyl peroxide application on the shoulder reduces Propionibacterium acnes: a randomized study.
    Scheer VM; Bergman Jungeström M; Lerm M; Serrander L; Kalén A
    J Shoulder Elbow Surg; 2018 Jun; 27(6):957-961. PubMed ID: 29609999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimizing topical combination therapy for the treatment of acne vulgaris.
    Zeichner JA
    J Drugs Dermatol; 2012 Mar; 11(3):313-7. PubMed ID: 22395581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical and oral antibiotics for acne vulgaris.
    Del Rosso JQ
    Semin Cutan Med Surg; 2016 Jun; 35(2):57-61. PubMed ID: 27416309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New developments in topical antimicrobial therapy for acne.
    Leyden J
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s8-11. PubMed ID: 18404865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
    Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
    J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzoyl peroxide use transiently decreases Cutibacterium acnes load on the shoulder.
    Duvall G; Kaveeshwar S; Sood A; Klein A; Williams K; Kolakowski L; Lai J; Enobun B; Hasan SA; Henn RF; Gilotra MN
    J Shoulder Elbow Surg; 2020 Apr; 29(4):794-798. PubMed ID: 31676186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic resistance in acne treatment.
    Humphrey S
    Skin Therapy Lett; 2012 Oct; 17(9):1-3. PubMed ID: 23032935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Systemic antibiotic therapy of acne vulgaris].
    Ochsendorf F
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S31-46. PubMed ID: 20482690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide.
    Heckmann N; Heidari KS; Jalali O; Weber AE; She R; Omid R; Vangsness CT; Rick Hatch GF
    J Shoulder Elbow Surg; 2019 Dec; 28(12):2279-2283. PubMed ID: 31471244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New treatment strategy in acne vulgaris. Antibiotic prescription must be limited].
    Mobacken H; Oprica C; Berg M
    Lakartidningen; 2012 May 30-Jun 4; 109(22):1085-9. PubMed ID: 22808657
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.